Goodwin, Guy M.; Aaronson, Scott T.; Alvarez, Oscar; Atli, Merve; Bennett, James C.; Croal, Megan; DeBattista, Charles; Dunlop, Boadie W.; Feifel, David; Hellerstein, David J.; Husain, Muhammad Ishrat; Kelly, John R.; Lennard-Jones, Molly R.; Licht, Rasmus W.; Marwood, Lindsey; Mistry, Sunil; Páleníček, Tomáš; Redjep, Ozlem; Repantis, Dimitris; Schoevers, Robert A.; Septimus, Batya; Simmons, Hollie J.; Soares, Jair C.; Somers, Metten; Stansfield, Susan C.; Stuart, Jessica R.; Tadley, Hannah H.; Thiara, Nisha K.; Tsai, Joyce; Wahba, Mourad; Williams, Sam; Winzer, Rachel I.; Young, Allan H.; Young, Matthew B.; Zisook, Sid; Malievskaia, Ekaterina
(Elsevier, 2023-04-14)
Background: COMP360 is a proprietary, synthetic formulation of psilocybin being developed for treatment-resistant depression (TRD), a burdensome, life-threatening illness with high global impact. Here, we expand upon the ...